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Mini-Abstract 
In Switzerland, the number, incidence, and cost of acute hospitalizations for major 
osteoporotic fractures and major cardiovascular events increased in both women and 
men between 2000 and 2008, although the mean length of stay was significantly 
reduced. Similar trend patterns were observed for hip fractures and strokes 
(decrease) and non-hip fractures and acute myocardial infarctions (increase). 
 
Abstract 
Purpose : To compare the trends and epidemiological characteristics of 
hospitalizations for major osteoporotic fractures (MOF) and other frequent diseases 
between year 2000 and 2008 in Switzerland. 
Methods : Trends in the number, age-standardized incidence, mean length of stay 
and cost of hospitalized MOF (hip, clinical spine, distal radius, and proximal 
humerus), major cardiovascular events (MCE: acute myocardial infarction, stroke, 
heart failure), chronic obstructive pulmonary disease (COPD), and breast carcinoma 
were compared in women and men aged ≥45 years, based on data from the Swiss 
Federal Statistical Office hospital database and population statistics. 
Results : Between 2000 and 2008, the age-standardized incidence of acute 
hospitalizations for MOF increased by 3.4% in women and 0.3% in men. In both 
sexes, a significant decrease in hip fractures (-15.0% and -11.0%) was compensated 
by a concomitant, significant increase in non-hip fractures (+24.8% and +13.8%). 
Similarly, the incidence of acute hospitalizations for MCE increased by 4.4% in 
women and 8.2% in men, as an aggregated result from significantly increasing acute 
myocardial infarctions and significantly decreasing strokes. While the mean length of 
stay in the acute inpatient setting decreased almost linearly between year 2000 and 
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2008 in all indications, the inpatient costs increased significantly (p<0.001) for MOF 
(+30.1%, +42.7%) and MCE (+22.6%, +47.1%) in women and men, respectively. In 
women in 2008, the cost of acute hospitalizations was more than threefold higher for 
MOF than for COPD and breast cancer and 1.5 fold higher than for any MCE. In men 
it was comparable to that of COPD, acute myocardial infarction, and heart failure.  
Conclusions : In conclusion, between year 2000 and 2008, the burden of hospitalized 
osteoporotic fractures to the Swiss healthcare system has continued to increase in 
both sexes. In women, this burden was significantly higher than that of major 
cardiovascular events and the gap between both disease groups widened over time. 
 
Key words 
osteoporosis, hip fracture, clinical spine fracture, distal radius fracture, proximal 
humerus fracture, acute myocardial infarction, stroke, heart failure, chronic 
obstructive pulmonary disease, breast cancer, epidemiology, cost, Switzerland. 
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Introduction 
Osteoporotic fractures are one of the leading causes of morbidity and mortality in 
industrialized countries [1]. While virtually any fracture may result as a complication 
from underlying osteoporosis, “typical” osteoporotic fractures occur at the hip, spine, 
distal forearm, and proximal humerus. Together, they are traditionally referred to as 
major osteoporotic fractures (MOF) [1-3].  
In year 2000, in all women living in Switzerland, the overall incidence of 
hospitalizations for any osteoporotic fracture was twice as high as that for breast 
cancer and pooled major cardiovascular events (MCE: acute myocardial infarction, 
stroke, and heart failure), and almost three times that of chronic obstructive 
pulmonary disease (COPD) [4]. In Swiss men, the overall incidence of 
hospitalizations for any osteoporotic fracture was half that of pooled MCE and two 
thirds of that of COPD [4]. As recently published, the age-standardized incidences of 
hospitalized MOF continued to increase in Swiss women and men aged 45 years and 
older between the year 2000 and 2007, driven by an increasing number and 
incidence of hospitalizations for non-hip fractures although the number of hip 
fractures was on the decline [5].  
The aim of the present analysis was to compare the trends and epidemiological 
characteristics, in female and male patients aged 45 years or older, of major 
osteoporotic fractures, major cardiovascular events, COPD, and breast carcinoma 
(women only) in Switzerland, between the years 2000 and 2008. Predefined 
parameters of interest were: absolute number and incidence of hospitalizations, 
number of hospital days due to fractures, and cost of hospitalizations.  
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Methods 
A summary of the data processing flow and relevant data sources is shown in Figure 
1. 
 
Selected ICD-10 codes 
Diseases were selected according to the 10th Edition of the International 
Classification of Diseases (ICD-10) issued by the World Health Organization [6]. 
Major osteoporotic fractures were divided into two categories: hip (ICD-10 codes 
S72.0 (fracture of the femoral neck), S72.1 (pertrochanteric fracture), and S72.2 
(subtrochanteric fracture)) and non-hip. Non-hip fractures were defined as: spine 
fractures coded S22.0 (fracture of the thoracic spine), S22.1 (multiple fractures of the 
thoracic spine), S32.0 (fracture of the lumbar spine), S32.7 (multiple fractures of the 
lumbar spine), and S32.8 (other fractures of the lumbar spine); fractures of the distal 
forearm coded as S52.5 (fracture of the distal radius) and S52.6 (combined fracture 
of the distal radius/ulna); fractures of the proximal humerus coded as S42.2 (fracture 
of the proximal humerus). 
Major cardiovascular events were defined as myocardial infarction coded I21 (acute 
myocardial infarction) and I22 (subsequent myocardial infarction); stroke coded I63 
(cerebral infarction), I64 (stroke, not specified as haemorrhage or infarction), I65 
(occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction), 
and I66 (occlusion and stenosis of cerebral arteries, not resulting in cerebral 
infarction); heart failure coded I50 (heart failure). Chronic obstructive pulmonary 
diseases were defined as codes J40 (bronchitis, not specified as acute or chronic), 
J41 (simple and mucopurulent chronic bronchitis), J42 (unspecified chronic 
bronchitis), J43 (emphysema), J44 (other chronic obstructive pulmonary disease), 
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J45 (asthma), J46 (status asthmaticus), and J47 (bronchiectasis). Breast carcinoma 
corresponded to the ICD-10 code C50 (malignant neoplasm of breast). 
 
Source of hospital statistics  
The administrative and medical statistics database of the Swiss Federal Statistical 
Office (SFSO) was used. All Swiss acute care hospitals, rehabilitation centers and 
specialized clinics, are obliged to supply their medical data to the SFSO (age, sex, 
number of hospitalizations coded according to the ICD-10 requirements, and duration 
of hospitalization). Data collection is coordinated by the SFSO. Data consistency and 
quality is ensured at the individual hospital, cantonal, and federal level through the 
mandatory use of a plausibility testing software developed by the SFSO [7]. This 
software performs more than 700 plausibility checks on single and pooled variables, 
including multiple interdependent variable testing and diagnostic code vs. treatment 
code testing). Inconsistencies and errors indicated in the log files are corrected at the 
appropriate level (individual hospital for source data, canton for inconsistencies 
across hospitals, and confederation for inconsistencies across cantons) following a 
feedback loop. This process ensures low error rates so that the level of plausibility of 
the reported diagnostic codes exceeds 95% [8]. Only medical data from Swiss acute 
hospital settings were retained for the present analysis. Data from rehabilitation 
centers and specialized clinics were excluded to prevent double counting. The 
degree of completeness for all records for years 2000 to 2008 was: 81.2%, 84.9%, 
95.0%, 94.1%, 96.2%, 98.2%, 98.5%, 98.6%, and 98.8%.  
Raw data for the number of hospitalizations for the selected ICD-10 codes and 
corresponding duration of hospitalization, were obtained for women and men aged 
≥45 years. Only the primary diagnostic code, i.e. the reason for hospitalization, was 
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considered for each patient to prevent double counting. All raw data were 
extrapolated pro-rata to 100% to compensate for incomplete coverage and to 
become representative for Switzerland as a whole.  
Data on the Swiss population structure between 2000 and 2008, split by 10-year age 
groups and sex, was also obtained from the SFSO. 
 
Epidemiological characteristics of hospitalizations 
The age-standardized incidence of hospitalizations, the number of patient-days spent 
in hospital and the mean length of hospital stay (LOS) per patient were calculated by 
10-year age groups starting from age 45 onwards and by sex, for all selected ICD-10 
codes grouped into the categories defined above. Annual crude incidences and 95% 
confidence intervals per 100’000 persons in years 2000 to 2008 were calculated by 
sex and 10-year age groups starting from age 45 onwards. Annual age-standardized 
incidences per 100’000 persons and 95% confidence intervals were calculated by 
sex based on 10-year age groups and adjusted for the age structure of the Swiss 
population in year 2000 according to a method published earlier [9]. Standardized 
incidence rate ratios and 95% confidence intervals were calculated to assess the 
change in incidence over time. As the goodness-of-fit of tentative Poisson regression 
models could not be confirmed, related time trends were assessed by fitting gender-
specific negative binomial models with ICD-10 code and year as covariates.  
The mean length of hospital stay was estimated by dividing the total number of 
patient-days spent in hospital by the number of hospitalizations. The cost of 
hospitalizations was estimated by multiplying the number of patient-days spent in 
hospital by the yearly average cost of one day in-hospital in Swiss Francs (CHF) 
between 2000 and 2008. The latter was obtained from yearly summary tables derived 
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from the hospital statistics database of the SFSO for each year of analysis and was 
not inflation adjusted [10]. The effects of time on mean length of stay and 
hospitalization cost was tested for statistical significance by the two-way ANOVA 
method. All calculations were done with the statistical software StatsDirect version 
2.7.8 (StatsDirect Ltd, Altrincham, Cheshire, UK). Negative binomial regression was 
performed in Stata/MP version 11.1 (Stata Corporation, College Station, Texas, 
USA). 
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Results 
Swiss population structure 
Between year 2000 and 2008, the number of women and men aged 45 years and 
older increased by 13.3 and 17.4%, respectively. 
 
Number of hospitalizations (Figure 2) 
Between 2000 and 2008, the absolute number of acute care hospitalizations for 
major osteoporotic fractures in patients aged ≥45 years increased from 13’948 to 
16’339 (+17.1%) in women and from 4’670 to 5’634 (+20.6%) in men, essentially 
driven by non-hip fractures (+41.3% and +34.6%, respectively). During the same 
time, the number of hip fractures decreased from 7’684 to 7’485 (-2.6%) in women 
and remained stable in men (from 2’538 to 2’765, +1%) in men. Similarly, the number 
of hospitalizations for major cardiovascular events increased from 9’530 to 11’271 
(+18.3%) and from 12’634 to 16’378 (+29.6%) in women and men, respectively. In 
contrast, the number of hospitalizations for COPD decreased from 5’115 to 4’210 (-
17.7%) and from 6’844 to 4’934 (-27.9%) in women and men, respectively. Finally the 
number of hospitalizations for breast cancer decreased from 9’400 to 7’650 (-18.6%) 
in women. 
 
Age-standardized incidence of hospitalizations 
In women, as shown in table 1A, the age-standardized incidence of hospitalized 
MOF increased by 3.4% between 2000 and 2008 (p for trend, 0.121), the significant 
decrease in hip fractures (-15.0%; p for trend, < 0.001 ) being fully compensated by a 
concomitant significant increase in hospitalized non-hip fractures (+24.8%; p for 
trend, 0.002). The latter resulted from an increase in hospitalized fractures of the 
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spine (+32.2%; p for trend, 0.008), the distal radius (+31.8%; p for trend, 0.005), and 
the proximal humerus (+10.3%, p for trend, 0.141). Similarly, the incidence of acute 
hospitalizations for major cardiovascular events increased by 4.4% (p for trend, 
0.558) during the observation period, as an aggregated result of a significant 
increase in acute myocardial infarctions (+29.5%; p for trend, 0.016) opposed by a 
significant decrease in hospitalized strokes (-17.8%; p for trend, 0.016), and with no 
change in the incidence of hospitalizations for heart failure (+0.8%; p for trend, 
0.926). Finally, the incidence of hospitalizations for COPD and breast cancer 
decreased significantly by 27.3% (p for trend, 0.016) and 28.2% (p for trend, < 
0.001), respectively. 
In men, as shown in table 1B, the incidence of hospitalized MOF did not change 
between 2000 and 2008 (+0.3%; p for trend, 0.918). The significant reduction in 
incident hip fractures (-11.0%; p for trend, 0.031) was totally offset by a significant 
increase in non-hip fractures (+13.8%; p for trend, 0.032), mainly driven by fractures 
of the distal radius (+29.2%; p for trend, < 0.001) and the proximal humerus (+12.5%; 
p for trend, 0.295). The incidence of acute hospitalizations for major cardiovascular 
events increased significantly by 8.2% (p for trend, 0.019). Interestingly, this overall 
increase resulted from an increase in hospitalizations for myocardial infarctions 
(+24.7%; p for trend, < 0.001) and heart failure (+8.5%; p for trend, 0.208) opposed 
by a significant reduction in the incidence of stroke (-28.1%; p for trend, 0.006). 
Finally, incident hospitalizations for COPD were significantly reduced by 39.7% (p for 
trend, 0.002). 
The overall pattern of changes in age-standardized incidences was consistent across 
sexes: decreasing incidences of hospitalizations for hip fractures and stroke, 
increasing incidences in hospitalizations for non-hip major osteoporotic fractures and 
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acute myocardial infarctions, decreasing incidence in hospitalizations for COPD. The 
observed increasing or decreasing trends in any disease category went in the same 
direction and were of similar magnitude in all age groups (figure 3).  
Patient-days in hospital and mean length of stay 
The total number of days spent during the acute hospitalization phase decreased 
almost linearly between year 2000 and 2008 in all indications of interest and in both 
sexes. In women, the highest relative decrease was observed for COPD (from 89’554 
to 56’099 days, -37.4%), followed by breast carcinoma (from 90’951 to 57’842days,  
-36.4%), major cardiovascular events (from 164’685 to 124’384 days, -24.5%), and 
major osteoporotic fractures (from 224’244 to 179’461, -19.9%). Therefore, 
hospitalization for MOF remains a major contributor of days spent in hospital by 
women aged 45 years or more, responsible of 3 times more days of hospitalization 
than COPD and breast cancer, and 1.5 times more days than any major 
cardiovascular event.  
In men, the highest relative decrease in days spent in hospital was observed for 
COPD (from 107’329 to 60’663, -43.5%) followed by major osteoporotic fractures 
(from 71’477 to 62’828, -12.1%), and major cardiovascular events (from 174’858 to 
158’441, -9.4%). Therefore, in 2008, there were as many days spent in hospital by 
men for COPD, acute myocardial infarction (67’997 days), and heart failure (57’822 
days) as for major osteoporotic fractures.  
These considerable reductions in total days spent in hospital for all indications of 
interest were essentially due to a relevant and statistically significant reduction of the 
mean length of stay (LOS) as shown in table 2. 
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Cost of hospitalizations  
As described above, the mean LOS for patients hospitalized because of fractures 
decreased substantially between 2000 and 2008. The effect of this was 
counterbalanced, however, by rising hospital costs: the mean cost per day of 
hospitalization increased from CHF 996.00 to CHF 1,618.00, over the same period, a 
rise of 62%. The effects on hospitalization costs by selected diagnostic codes are 
shown in figure 4.  
In women, hospitalization cost for major osteoporotic fractures increased from CHF 
223 mio to 291 mio (+30.1%, p<0.001 for time trend) and from 164 to 201 mio 
(+22.6%, p<0.001) for major cardiovascular events. The cost of hospitalizations for 
COPD and breast cancer remained almost unchanged (from CHF 89 to 91 mio, 
+1.7%, p= 0.168 and from 91 to 94 mio, +3.3%, p=0.003, respectively). Overall, in 
women in 2008, the cost of acute hospitalizations was more than threefold higher for 
major osteoporotic fractures than for COPD and breast cancer and 1.5 fold higher 
than for any major cardiovascular event. As shown in figure 5, osteoporotic fractures 
contributed to approximately 60% of the total costs of MOF and MCE in women.  
In men, the cost of acute hospitalizations for major osteoporotic fractures and major 
cardiovascular events between 2000 and 2008 increased by 42.7% (from CHF 71 to 
102 mio, p<0.001 for time trend) and by 47.1% (from CHF 174 to 256 mio, p<0.001), 
respectively. Therewhile, the cost of hospitalizations for COPD was reduced by 8.2% 
(from CHF 107 to 98 mio, p=0.078). Overall, in men in 2008, the cost of acute 
hospitalizations for MOF was comparable to that of COPD, acute myocardial 
infarction (CHF 110 mio), and heart failure (CHF 94 mio). As shown in figure 5, 
osteoporotic fractures represented approximately 30% of the total costs of MOF and 
MCE in men.
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Discussion 
The present analysis reports the epidemiological characteristics of hospitalizations in 
the acute care setting of patients with major osteoporotic fractures, major 
cardiovascular events, chronic obstructive pulmonary disease, or breast carcinoma in 
Switzerland between year 2000 and 2008. For the first time, time trends were 
established by using a nationwide database of medical records following an identical 
methodology, which ensures highest possible homogeneity in results and should 
allow for comparisons with only little potential for bias. In this analysis, the age-
standardized rates of hospitalizations for MOF and MCE increased during the 
observation period, driven by an increase in non-hip fractures and acute myocardial 
infarctions, respectively. In addition, the mean length of hospital stay decreased 
significantly in all indications of interest, the cost effect of which was offset by the 
increase in cost per day of hospitalization. Overall, the total cost of hospitalizations, 
which aggregates the cost effect of the number of hospitalizations, mean length of 
hospital stay, and cost per day of hospitalization, increased by 30% and 43% for 
MOF and 23 and 47% for MCE in women and men, respectively. The total cost 
incurred by hospitalizations for COPD and breast cancer remained virtually 
unchanged. During the same time, hospitalizations for hip fractures, stroke, COPD, 
and breast cancer decreased significantly. Reported changes followed similar 
patterns in both sexes, although of different orders of magnitude.  
In Swiss women, during the 9 years of observation, osteoporosis and its 
complications, as measured by the characteristics of hospitalizations for major 
osteoporotic fractures, remained a key contributor to the economic burden of 
healthcare. As confirmed by the present analysis, hip fractures seem on the decline 
in Swiss women which confirms earlier findings from our group [5] and others [11, 
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12]. This possible reversal of a secular trend is consistent with reports from other 
countries such as USA [13-15], Canada [16, 17], Japan [18], Finland [19], and 
Denmark [20]. Similar observations were made in neighbour countries such as 
France [21] and Austria [22] but not in Italy [23] and Germany [24, 25]. In contrast, 
the incidence of hospitalizations for non-hip fractures steadily increased between 
year 2000 and 2008 in Swiss women. This effect was observed for all localizations of 
non-hip fractures (spine, distal radius, and proximal humerus). Possible explanations 
will remain speculative and were detailed elsewhere [5]. We are not aware of other 
publications confirming or infirming this observation with the exception of earlier 
reports from Finland which indicated that low-trauma knee [26], ankle [27], and distal 
humeral [28] fractures may be stabilizing or even declining in this country. 
Importantly, the present analysis reports hospitalized fractures only. Whether the total 
incidence of hospitalized and non-hospitalized non-hip fractures has increased 
cannot be concluded from the present data. However, as ongoing health care reform 
efforts have led to a global shift from inpatient to outpatient care [29], the matter 
deserves further investigation. The age-standardized incidence of hospitalizations for 
hip and non-hip fractures in men followed a similar pattern as in women but with a 
lower magnitude of change.  
Interestingly, in women, the incidence of hospitalizations for acute myocardial 
infarctions increased strongly while they stagnated for heart failure and decreased for 
stroke with a similar pattern in men. Although a milestone regarding the 
characteristics of acute coronary syndromes in the real world was achieved already 
in 1997 by launching the AMIS (Acute Myocardial Infarction in Switzerland) and AMIS 
Plus registry [30], we are not aware of previously published trend patterns for 
hospitalized major cardiovascular events in Switzerland. An increasing number of 
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publications reports the association between cardiovascular diseases and 
osteoporotic fractures. Among the very first indices in this regard, a Swedish registry 
collected 273’288 strokes and 24’666 fractures, of which 14’263 hip fractures, 
between 1987 and 1996 and concluded that after a hospitalization for stroke, there 
was a more than 7-fold increase in fracture risk during the first year after 
hospitalization for stroke [31]. In 2007, Sennerby et al showed that women with 
cardiovascular disease had a substantially increased risk of hip fracture, suggesting 
possible common pathologic pathways for osteoporotic fractures and cardiovascular 
diseases [32]. In addition, in a cohort of 31’936 Swedish twins born in 1914-1944 
followed up from the age of 50 years, the same authors reported that a diagnosis of 
cardiovascular disease was significantly associated with risk of subsequent hip 
fracture within the same individual and in his or her co-twin without index diagnosis 
[33]. In the present analysis, we report an increasing incidence of both major 
osteoporotic fractures and major cardiovascular diseases between 2000 and 2008 in 
Switzerland, which is consistent with a possible association between both disease 
entities. We also report decreasing trends in hip fractures and stroke and increasing 
trends in non-hip fractures and acute myocardial infarctions, which raises the 
question whether the supposed association between osteoporosis and 
cardiovascular diseases might be more multifaceted than suggested to date. 
The present analysis based on data of the medical database of the SFSO did not 
allow for identification of potential underlying associations or causes for the reported 
time trends. The earlier mentioned prospective AMIS Plus registry collects 230 
variables of patients hospitalized for acute coronary syndromes in 76 Swiss hospitals 
participating on a voluntary basis. If a similar registry existed for osteoporotic 
fractures, ideally in the same or a subset of the AMIS hospitals, database linkages 
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could offer a unique opportunity for exploring further the associations between 
fractures and cardiovascular diseases. Furthermore, both fractures and major 
cardiovascular events often lead to patient discharge to a rehabilitation center. Here 
again, a fracture registry combined with AMIS Plus could possibly contribute to 
identify common prognostic factors and to improve outcomes. 
The present analysis reports hospitalized clinical events only. It is well known that 
many osteoporotic fractures are treated in the outpatient setting. Based on data from 
the Swiss nationwide survey in the OsteoCare cohort, which included 3667 
consecutive women and men aged 50 years and older and presenting to the 
emergency ward of participating hospitals with a fragility fracture [34], virtually all hip 
fractures, approximately half of proximal humerus fractures, one third of distal radius 
fractures, and one fourth of clinical spine fractures were hospitalized in Switzerland 
[3]. These observations are broadly consistent with reports from other countries [35]. 
On the other hand, as many as 25% of all coronary events are lethal before the 
patient reaches the hospital, a proportion that continues to increase as a result of the 
decline in in-hospital deaths observed during the past decades [36]. Therefore, the 
proposed comparisons across diseases should be considered as restricted to 
hospitalizations only.  
We reported on major osteoporotic fractures, i.e. of a subset of all hospitalized 
osteoporotic fractures. Achieving completeness would have required the very 
cumbersome use of osteoporosis attribution rates, as was exemplified earlier [4, 37]. 
Using the present approach, major osteoporotic fractures were estimated to 
represent only 77 and 72% of attributable fractures in women and men in year 2000, 
respectively [3-5]. Therefore, absolute numbers, incidences, hospital days and 
related costs reported in the analysis should be considered conservative. Data 
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completeness was 81.2% and 84.9% in years 2000 and 2001, respectively, and 
exceeded 95.0% thereafter. The extrapolation to 100% could have induced a 
selection bias when comparing year 2008 with 2000. However, the trends observed 
over the 9 years were consistent year over year in all diseases of interest and no 
outliers were identified.   
Of note, the total cost estimate for osteoporotic fractures (CHF 393 mio) reported in 
the present analysis refers to direct medical costs of acute hospitalizations for MOFs 
only. The total direct medical cost of all hospitalized osteoporotic fractures can be 
extrapolated to CHF 524 mio, to which the inpatient rehabilitation and nursing home 
costs should be added. These represent approximately 50% of the total cost of the 
inpatient management of osteoporotic fractures, as already published earlier by our 
group [38], so that the total cost of treating hospitalized osteoporotic fractures in 
Switzerland exceeded CHF 1 billion in 2008.  Cost estimates calculated in the 
present analysis are based on the nationwide average real cost per day of 
hospitalization and not on discipline-specific costs or Diagnosis Related Groups 
(DRGs). Therefore, cost estimates should be regarded as approximations, until the 
introduction of the DRG system will allow more precise estimates.  
Finally, we did not attempt a projection based on observed trends. According to 
demographic scenarios from the SFSO, the Swiss population older than 65 years of 
age will almost have doubled in 2050 [39]. Therefore, assuming the current time 
trends remaining unchanged, the declining incidence of hip fractures and strokes will 
not be sufficient to reduce the absolute number of hospitalizations for these diseases 
in the coming decades. A representative cohort or a fracture registry linked to the 
AMIS Plus registry would contribute to better anticipation of future trends and allow 
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for monitoring the effects of public health measures aimed at reducing fracture and 
cardiovascular risk. 
In conclusion, between year 2000 and 2008, the burden of hospitalized osteoporotic 
fractures to the Swiss healthcare system has continued to increase in both sexes. In 
women, this burden was significantly higher than that of major cardiovascular events 
and the gap between both disease groups widened over time. More research is 
warranted to better understand the causal drivers behind these trends. 
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Tables and figures 
 
Figure legends  
 
 
Figure 1: Data sources and data processing flow. SFSO = Swiss Federal Statistical Office; ICD = International Classification of 
Diseases; COPD = Chronic Obstructive Pulmonary Diseases. 
 
Figure 2: Number of acute care hospitalizations in women (A) and men (B) for selected diseases between year 2000 and 2008 
 
Figure 3: Age-standardized incidence of hospitalizations per 100’000 in women (A) and men (B) aged 45 years or more by 10-year 
age groups  
 
Figure 4: Cost of acute hospitalizations in women (A) and men (B) aged 45 years and older (mio. CHF) 
 
Figure 5: relative cost contribution of major osteoporotic fractures and major cardiovascular events in women (A) and men (B) aged 45 
years and older between year 2000 and 2008. 
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Table 1: age-standardized incidence of hospitalizations per 100’000 women (A) and men (B) aged 45 years or more (95% 
confidence interval) 
 
Table 1A 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 Incidence rate ratio  2008 vs 2000 (95% CI) 
Major osteoporotic fractures 901 976 955 965 942 942 964 933 925 1.03 
 
(886-916) (961-992) (940-970) (950-980) (928-957) (927-956) (949-978) (919-948) (911-939) (1.00-1.05) 
Hip fractures 496 535 500 488 460 439 435 433 421 0.85 
 
(485-507) (524-546) (489-511) (478-499) (450-471) (429-449) (425-445) (423-443) (411-430) (0.82-0.87) 
Non-hip fractures 405 441 455 477 482 503 529 500 504 1.25 
 
(395-415) (431-452) (444-465) (466-488) (471-493) (492-513) (518-540) (490-511) (494-515) (1.21-1.29) 
Spine fractures 84 93 93 95 91 95 97 107 110 1.32 
 
(79-88) (88-97) (88-98) (90-100) (86-95) (90-98) (92-102) (102-112) (105-115) (1.23-1.41) 
Distal radius fractures 187 207 216 240 236 263 276 246 246 1.32 
 
(180-194) (200-214) (209-223) (233-248) (299-244) (255-271) (268-284) (238-253) (239-254) (1.26-1.38) 
Proximal humerus fractures 134 141 145 141 155 145 156 148 148 1.10 
 (128-140) (135-147) (139-151) (136-147) (149-161) (139-150) (150-161) (142-154) (142-153) (1.04-1.17) 
Major CV events 615 622 558 539 525 514 564 577 639 1.04 
 
(603-628) (610-634) (546-569) (527-550) (514-536) (503-525) (552-575) (565-590) (627-651) (1.01-1.07) 
Acute myocardial infarction 190 202 188 183 177 179 200 211 246 1.29 
 
(183-197) (195-209) (181-194) (176-189) (170-183) (173-186) (193-206) (204-218) (239-254) (1.23-1.36) 
Stroke 175 175 140 138 132 123 128 121 143 0.82 
 
(169-182) (168-181) (134-146) (132-144) (127-138) (118-128) (123-133) (116-126) (138-149) (0.78-0.86) 
Heart failure 250 245 230 218 215 211 236 245 249 1.00 
 
(242-258) (237-253) (223-237) (211-225) (208-222) (205-218) (229-243) (238-252) (242-257) (0.96-1.04) 
COPD 330 295 279 265 252 256 241 268 241 0.73 
 
(321-339) (286-303) (271-287) (257-273) (244-260) (248-263) (234-249) (261-276) (234-248) (0.70-0.76) 
Breast carcinoma 607 612 535 546 493 470 453 428 438 0.72 
 
(595-619) (600-624) (523-546) (535-557) (483-504) (459-480) (443-463) (419-438) (428-447) (0.70-0.74) 
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Table 1B 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 Incidence rate ratio  2008 vs 2000 (95% CI) 
Major osteoporotic fractures 351 375 351 366 354 356 362 360 352 1.00 
 
(341-361) (364-385) (341-361) (353-373) (344-364) (347-366) (353-372) (350-369) (343-361) (0.96-1.04) 
Hip fractures 191 197 186 182 174 164 176 166 170 0.89 
 
(183-198) (189-204) (179-193) (175-189) (168-181) (158-171) (164-178) (160-172) (163-176) (0.84-0.94) 
Non-hip fractures 160 178 165 181 180 192 191 194 182 1.14 
 
(153-167) (171-185) (158-171) (174-188) (173-187) (185-199) (184-198) (187-201) (175-189) (1.07-1.20) 
Spine fractures 64 67 60 66 67 65 67 74 67 1.04 
 
(60-68) (63-72) (56-64) (62-70) (63-71) (61-69) (63-71) (70-79) (63-71) (0.95-1.14) 
Distal radius fractures 48 53 55 61 58 64 68 63 62 1.29 
 
(44-51) (49-57) (51-58) (57-65) (54-62) (60-68) (63-72) (59-67) (58-66) (1.17-1.43) 
Proximal humerus fractures 48 57 51 54 55 63 57 57 54 1.11 
 (45-52) (53-61) (47-54) (50-58) (51-59) (59-67) (53-61) (53-60) (50-57) (1.00-1.23) 
Major cardiovascular  events 949 972 896 873 865 864 984 1'009 1'027 1.08 
 
(932-965) (956-989) (880-912) (857-888) (850-880) (850-879) (969-1000) 993-1024) (1011-1042) (1.06-1.11) 
Acute myocardial infarction 458 463 449 435 429 438 510 535 571 1.25 
 
(446-469) (452-474) (438-460) (424-445) (419-440) (427-448) (498-521) (523-546) (560-583) (1.21-1.29) 
Stroke 210 203 176 177 173 161 167 153 151 0.72 
 
(202-217) (195-210) (169-183) (170-184) (167-180) (155-168) (160-173) (147-159) (145-157) (0.68-0.76) 
Heart failure 281 307 271 261 262 266 308 321 305 1.08 
 
(272-290) 298-316) (262-280) (253-270) (253-270) (257-274) (299-316) (312-330) (296-313) (1.04-1.13) 
COPD 514 458 415 399 369 386 353 365 310 0.60 
 
(502-526) (447-469) (404-426) (388-409) (359-379) (376-396) (343-362) (355-374) (301-319) (0.58-0.63) 
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Table 2:Changes in mean length of hospital stay (days) in women (A) and men (B)  
 
Table 2A 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 Change  2008 vs 2000 (%) 
p-value  
for time effect 
Major osteoporotic fractures 16.1 15.0 14.6 13.8 12.9 12.2 11.5 11.4 11.0 -31.6% <0.001 
Hip fractures 19.0 17.8 17.9 17.6 16.5 16.0 14.9 14.7 14.0 -26.5% <0.001 
Non-hip fractures 12.4 11.5 11.0 9.9 9.4 8.8 8.7 8.6 8.5 -32.1% <0.001 
Spine fractures 16.7 14.8 16.7 15.6 13.9 13.4 13.4 12.3 12.6 -24.5% <0.001 
Distal radius fractures 8.7 8.3 7.0 6.2 6.3 5.7 5.5 5.6 5.4 -38.3% <0.001 
Proximal humerus fractures 15.0 14.2 13.2 12.4 11.6 11.5 11.3 10.9 10.5 -30.1% <0.001 
Major CV events 17.3 16.1 15.4 15.2 14.6 13.4 12.7 12.0 11.0 -36.1% <0.001 
Acute MI 12.6 12.1 11.9 11.2 10.2 9.6 9.4 9.3 9.5 -24.1% <0.001 
Stroke 23.7 21.6 20.7 20.7 19.8 18.2 16.7 14.8 10.7 -55.1% <0.001 
Heart failure 16.4 15.6 15.2 15.0 15.0 13.8 13.4 13.1 12.7 -22.2% 0.006 
COPD 17.5 16.8 16.8 15.3 14.7 13.6 13.8 13.3 13.3 -23.9% <0.001 
Breast carcinoma 9.7 9.2 8.9 8.7 8.2 7.7 7.7 7.6 7.6 -21.9% <0.001 
 
Table 2B 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 Change  2008 vs 2000 (%) 
P value  
for time effect 
Major osteoporotic fractures 15.3 14.0 13.9 13.3 12.5 11.5 11.7 11.2 11.2 -27.1% <0.001 
Hip fractures 18.8 17.2 17.4 16.7 15.9 15.2 15.1 14.4 13.8 -27.0% <0.001 
Non-hip fractures 11.1 10.5 10.0 9.7 9.2 8.3 8.6 8.4 8.6 -22.1% <0.001 
Spine fractures 13.9 13.5 13.7 12.3 11.5 10.5 11.3 10.3 11.0 -20.9% <0.001 
Distal radius fractures 6.0 6.1 5.5 5.7 5.3 5.3 5.0 4.8 5.3 -12.0% 0.184 
Proximal humerus fractures 12.4 11.1 10.4 11.1 10.4 9.2 9.6 10.0 9.6 -23.1% 0.004 
Major CV events 13.8 13.1 12.0 11.7 11.4 10.5 10.2 9.8 9.7 -30.1% <0.001 
Acute MI 9.4 9.3 8.6 8.2 8.0 7.5 7.4 7.3 7.5 -19.8% <0.001 
Stroke 23.0 20.8 19.2 18.6 18.1 15.6 15.3 13.7 13.5 -41.3% <0.001 
Heart failure 14.3 13.9 12.9 12.7 12.6 12.2 12.0 11.9 11.7 -17.7% 0.225 
COPD 15.7 15.7 14.4 14.4 13.6 12.9 13.0 12.5 12.3 -21.6% <0.001 
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